Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA Trial
Clinical trial NCT05898646 · RECRUITING
Trial details
- NCT number
- NCT05898646
- Sponsor
- Mayo Clinic
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-17
- Primary completion
- 2026-11-30
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.